WisdomTree Global ex-U.S. Quality Growth Fund DNL
Set alert
At close · Oct 30
After hours · Oct 30, 7:30 PM ET
- YTD
- +5.01%
- 1 year
- +4.86%
- Open
- 43.61
- Prev close
- 44.62
- Mkt cap
- 476.56M
- Vol
- 17.13K
- Avg vol
- 16.15K
- EPS
- 1.88
- P/E
- 23.04
- Div yield
- 0.00%
More statistics
- Low
- 42.91
- High
- 43.61
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 37.56
- 200-d avg
- 38.59
News
1 month ago benzinga.com
What's Going On With Shopify Stock Tuesday?
Shopify (SHOP) fell nearly 8% as investors rotated away from high-multiple growth stocks despite strong Q2 earnings. Learn more.
10 months ago globenewswire.com
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics' Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
SOUTH SAN FRANCISCO, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the publication of results from the open-label Phase 1/2 clinical trial of its…
10 months ago seekingalpha.com
Denali: Maintaining Strong Buy Based On DNL126 Expansion As MPS IIIA Treatment
Denali Therapeutics Inc. is maintained at a Strong Buy rating, driven by progress in its MPS II [Hunter Syndrome] program with tividenofusp alfa. Despite discontinuing ALS efforts, DNLI's BLA for…
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) was launched on 06/16/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the World ETFs category of the…
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
A smart beta exchange traded fund, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) debuted on 06/16/2006, and offers broad exposure to the World ETFs category of the market.
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
1 year ago seekingalpha.com
DNL: Lagging Its Peers For A While
WisdomTree Global ex‐U.S. Quality Dividend Growth Fund holds 300 ex-US dividend stocks, focusing on quality and growth metrics. DNL is diversified across holdings, sectors, and countries, with…
1 year ago globenewswire.com
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
SOUTH SAN FRANCISCO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the company's initiation of a rolling submission of a biologics license…
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
1 year ago seekingalpha.com
Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
Denali Therapeutics' stock has significantly dropped from $100 to $15 since 2021, but the company is now heavily derisked with promising product candidates nearing key milestones. Lead asset DNL310…
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
1 year ago globenewswire.com
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced topline results from an analysis of Regimen G of the Phase 2/3 HEALEY ALS…
1 year ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on…
2 years ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
2 years ago globenewswire.com
Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the outcome of a recent successful meeting with the Center for Drug Evaluation…
2 years ago seekingalpha.com
Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology
Denali Therapeutics' proprietary Transport Vehicle technology enables drug delivery across the blood-brain barrier, targeting neurodegenerative diseases. DNL310, targeting MPS II, and DNL343 for ALS…
2 years ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Launched on 06/16/2006, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.
2 years ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the World ETFs category of the…
2 years ago zacks.com
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
The WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the World ETFs category of the…
2 years ago seekingalpha.com
ICOW: Attractive Fundamentals, Average Performance
ICOW: Attractive Fundamentals, Average Performance
2 years ago seekingalpha.com
DNL: Successfully Combining Quality, Dividend, And Growth
WisdomTree Global ex‐U.S. Quality Dividend Growth Fund ETF holds about 300 international dividend stocks with quality and earnings growth characteristics. The portfolio is well-diversified across…
-
4 years ago benzinga.com
Denali Therapeutics Late Wednesday Announces Pricing Of $275M Public Offering Of 10,377,359 Shares Of Common Stock For $26.50 Per Share
Denali Therapeutics Inc. (NASDAQ:DNLI) today announced the pricing of its underwritten public offering of 10,377,359 shares of its common stock at a price to the public of $26.50 per share. All of…
-
13 years ago benzinga.com
New ETF Brings Dividend Growth Concept to Emerging Markets
New ETF Brings Dividend Growth Concept to Emerging Markets
-
13 years ago benzinga.com
Three Ex-U.S. ETFs Your Broker Forgot to Mention
Three Ex-U.S. ETFs Your Broker Forgot to Mention
-
14 years ago benzinga.com
4 "Ex" ETFs Your Broker Forgot to Mention (DTN, AXEN, FDT)
4 "Ex" ETFs Your Broker Forgot to Mention (DTN, AXEN, FDT)
-
14 years ago benzinga.com
Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer
Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer
-
15 years ago benzinga.com
Five International Dividend ETFs Your Broker Forgot to Mention
Five International Dividend ETFs Your Broker Forgot to Mention
-
15 years ago benzinga.com
Immunomedics Reports First Clinical Results of New Antibody-Directed Radiation Therapy for Colorectal Cancer
Immunomedics Reports First Clinical Results of New Antibody-Directed Radiation Therapy for Colorectal Cancer
-
17 years ago benzinga.com
Goldman Sachs Expects A Correction In Asian Stocks In 2010 (EWY, FXI, SCJ, DNL)
Goldman Sachs Expects A Correction In Asian Stocks In 2010 (EWY, FXI, SCJ, DNL)